We take great responsibility to help improve patients’ lives and see ourselves as a vital link between our customers and their patients – together, we create a safe and innovative healthcare environment of tomorrow. Our state-of-the-art solutions for parenteral drug packaging are supplied to leading pharmaceutical and biotech companies worldwide.
At Datwyler, we are dedicated to meeting customer expectations by guaranteeing the highest level of quality and safety and continuing to make investments aimed at meeting the ever-changing regulatory requirements of the industry. Thanks to our sophisticated product know-how, high-quality manufacturing processes provided on a global scale, and our strong partnerships, we offer best-in-class solutions and enable our customers around the globe to realize their full healthcare potential.




Datwyler in the news

Drug defence: designing against defects.
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.

Securing the supply.
Navigating pharma’s packaging challenges amid a pandemic.

The Process of Pharmaceutical Elastomer Selection for Injectable Biologics.
Datwyler discusses five considerations for drug manufacturers to consider when selecting parenteral packaging for their drug products.

Preserving the parenterals of tomorrow.
Glenn Thorpe, Senior Vice President, Pharma at Datwyler, says pharmaceutical companies should engage with packaging suppliers that can meet the industry demands of the pandemic.

Drug Protection: Eliminate Defects.
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.